News Sentiment

CGC sentiment intelligence

Canopy Growth Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 56 Balanced news tone 58 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 0.97 Week of 10 Jul 2026
Weighted tone 56/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

81/100 classification confidence.

Company focus 58

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-2.9% over one week, -2.9% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

Canopy Growth: Is Another Reverse Stock Split Inevitable?

Market Reaction

Balanced read

66/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 81/100 classification
One-week reaction -2.9% Price reacting lower
Trend fit Trend inactive -2.9% over four weeks
Fair value -72.4% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 32
Neutral 17
Negative 9

Relevance

Why the article matched

Direct first
Direct company coverage 58
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 18
Stock Titan 14
The Motley Fool 7
TradingView 5
AlphaStreet 2
AOL.com 1
Sahm 1
Moomoo 1

Event Lens

What the news is about

Classified themes
Market update 35
Earnings 17
Balance sheet 3
Deals and strategy 2
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 58
TradingView Direct company coverage

Price to sales forward of Canopy Growth Corporation – GETTEX:11L

This article provides financial information for Canopy Growth Corporation (GETTEX:11L), specifically focusing on its price-to-sales forward ratio. It appears to be a stub or data-centric page from TradingView, presenting financial metrics and market data without detailed analysis

Tone
Neutral 50/100
Event
Market update
Published
13 Jul 2026 14:40
Source
TradingView
Moomoo Direct company coverage

Canopy Growth 4Q Rev C$71.2M >WEED.T

Canopy Growth reported fourth-quarter revenue of C$71.2 million, as indicated by the >WEED.T ticker. This brief update provides key financial data for the company.

Tone
Neutral 50/100
Event
Earnings
Published
08 Jul 2026 13:11
Source
Moomoo
Market source Direct company coverage

Is Canopy Growth Stock Finally Worth Buying After Losing 99% of Its Value?

Canopy Growth (NASDAQ: CGC) stock has lost over 99% of its value since its 2018 peak, prompting the question of whether it's now a buying opportunity. While the company has shown improvements in fiscal 2026, including revenue growth and a stronger balance sheet, it remains unprof

Tone
Negative 40/100
Event
Earnings
Published
08 Jul 2026 09:05
Source
Market source
Market source Direct company coverage

Canopy Growth Corporation (CGC) Declines More Than Market: Some Information for Investors

Canopy Growth Corporation (CGC) recently saw its stock decline by 1.04%, lagging behind broader market indices like the S&P 500. Investors are anticipating the company's upcoming earnings report, which projects a significant increase in EPS and revenue compared to the previous ye

Tone
Negative 37/100
Event
Earnings
Published
07 Jul 2026 22:09
Source
Market source
AD HOC NEWS Direct company coverage

Canopy Growth stock leans on operations and cash discipline

Canopy Growth Corp. is being assessed on its operational execution, cost management, and liquidity rather than just ambitious headlines. The company's focus on efficiency and a narrower operating scope is crucial for its financial profile, especially as investors closely monitor

Tone
Positive 60/100
Event
Balance sheet
Published
07 Jul 2026 12:08
Source
AD HOC NEWS
StocksToTrade Direct company coverage

Canopy Growth CGC Stock Builds Turnaround Momentum After FY2026 Reset

Canopy Growth (CGC) is showing signs of a turnaround, with its core cannabis business returning to top-line growth in FY2026, driven by gains in Canadian adult-use, medical, and international cannabis revenue. The company also improved its balance sheet by shifting to a net cash

Tone
Positive 74/100
Event
Earnings
Published
02 Jul 2026 17:39
Source
StocksToTrade
Market source Direct company coverage

Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: Here's Why

Canopy Growth Corporation (CGC) stock fell by 4.45% while the broader market gained, trailing the S&P 500 and the Medical sector over the last month. Analysts anticipate CGC to report earnings of -$0.04 per share, a 71.43% year-over-year growth, and foresee a 12.25% revenue incre

Tone
Negative 36/100
Event
Earnings
Published
30 Jun 2026 22:09
Source
Market source
Stock Titan Direct company coverage

Tax-related RSU share sale by Canopy Growth Corp (CGC) director detailed in Form 4

Canopy Growth Corp director M. Shan Atkins reported a tax-related sale of 3,197 common shares at $0.9237 per share on June 26, 2026. This disposition was associated with tax obligations arising from the vesting of restricted stock units (RSUs) granted on June 17, 2026. Following

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 20:17
Source
Stock Titan
Stock Titan Direct company coverage

Tax-related share sale by Canopy Growth (CGC) director after RSU vesting

Canopy Growth Corp (CGC) director Joseph Bayern sold 3,197 common shares at $0.9237 per share. This sale was a tax-related disposition connected to the vesting of restricted stock units (RSUs) granted on June 17, 2026, and not a discretionary open-market sale. After the transacti

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 20:17
Source
Stock Titan
Stock Titan Direct company coverage

Tax-driven share sale by Canopy Growth Corp (CGC) director Theresa Yanofsky

Canopy Growth Corp director Theresa Yanofsky sold 15,054 common shares on June 26, 2026, for $0.9237 per share. This transaction was not a discretionary trade but rather for tax obligations arising from the vesting of restricted stock units granted on June 17, 2026. Following the

Tone
Negative 39/100
Event
Market update
Published
29 Jun 2026 20:17
Source
Stock Titan
TradingView Direct company coverage

Canopy Growth Corporation Actuals & Estimates (TRADEGATE:11L)

This article provides an overview of Canopy Growth Corporation (TRADEGATE:11L) financials and analyst estimates. It covers historical financial data, future price forecasts, earnings reports, revenue, net income, employee count, and EBITDA. The company does not pay dividends and

Tone
Negative 39/100
Event
Earnings
Published
26 Jun 2026 16:40
Source
TradingView
Market source Direct company coverage

Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It

Canopy Growth Corporation (CGC) is currently a trending stock, attracting attention from investors. This article reviews factors influencing its near-term performance, including earnings estimate revisions, projected revenue growth, and valuation. The company's Zacks Rank #3 (Hol

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 13:10
Source
Market source
Stock Titan Direct company coverage

108K-share RSU award to Canopy Growth (CGC) director Theresa Yanofsky

Canopy Growth Corp (CGC) director Theresa Yanofsky received an equity award of 108,324 common shares in the form of Restricted Stock Units (RSUs) on June 17, 2026. These RSUs, granted at no cash cost, will vest in four equal installments between June 2026 and March 2027. Followin

Tone
Neutral 50/100
Event
Balance sheet
Published
23 Jun 2026 12:39
Source
Stock Titan
Stock Titan Direct company coverage

Canopy Growth (NASDAQ: CGC) director receives 162,485-share equity grant, lifting holdings

Canopy Growth Corp director David Angelo Lazzarato received an equity award of 162,485 Common Shares on June 17, 2026, as a compensation-related grant in the form of restricted stock units (RSUs). This grant, which was at no cash cost, increases his direct holdings to 234,533 Com

Tone
Neutral 50/100
Event
Balance sheet
Published
23 Jun 2026 12:39
Source
Stock Titan
Stock Titan Direct company coverage

Canopy Growth (CGC) officer granted RSUs and options, sells 9,285 shares

A Canopy Growth Corp (CGC) officer, Stewart Thomas Carlton, was granted 379,018 restricted stock units (RSUs) and 463,347 stock options, while also selling 9,285 common shares. The share sale was primarily to cover tax obligations stemming from previous RSU vesting. Following the

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 06:40
Source
Stock Titan
Stock Titan Direct company coverage

Canopy Growth (CGC) officer gains major equity awards, sells shares to cover tax

Canopy Growth Corp officer Christelle Gedeon received significant equity awards, including 396,012 common shares and stock options for 484,122 shares. On the same day, she sold 58,994 common shares at $0.9741 per share to cover tax obligations related to previously vested restric

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 06:40
Source
Stock Titan
Stock Titan Direct company coverage

Canopy Growth (CGC) director receives 108K-share RSU grant

Canopy Growth Corp. director ATKINS M SHAN was granted 108,324 Common Shares in the form of restricted stock units (RSUs) on June 17, 2026, as compensation. These RSUs, valued at $0.00 per share, will vest in four equal installments between June 2026 and March 2027. Following thi

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 20:10
Source
Stock Titan
Stock Titan Direct company coverage

Director at Canopy Growth (CGC) receives 108K-share restricted stock grant

Joseph Bayern, a director at Canopy Growth Corp (CGC), was granted 108,324 restricted stock units (RSUs) on June 17, 2026. These RSUs, a form of stock-based compensation, will vest in four equal installments between June 26, 2026, and March 29, 2027. Following this grant, Bayern

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 20:10
Source
Stock Titan
Stock Titan Direct company coverage

Canopy Growth (CGC) CEO granted RSUs, options and disposes shares for tax

Canopy Growth Corp's CEO, Luc Mongeau, received a significant equity compensation package including 1,056,152 restricted stock units (RSUs) and stock options for 1,291,139 common shares. Concurrently, Mongeau disposed of 135,231 common shares to cover tax obligations arising from

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 20:10
Source
Stock Titan
AlphaStreet Direct company coverage

Canopy Growth Reports 300.0% Wider Q4 2026 Loss at -$0.40/Share

Canopy Growth Corporation reported a Q4 2026 diluted loss of C$0.40 per share, which was substantially wider than the C$0.10 loss analysts anticipated. Despite missing Wall Street forecasts, the stock remained largely unchanged, suggesting investors may have already accounted for

Tone
Negative 36/100
Event
Market update
Published
16 Jun 2026 16:40
Source
AlphaStreet
TradingView Direct company coverage

CGC Q4 Earnings Call Focuses on EBITDA Path

Canopy Growth Corporation (CGC) used its Q4 earnings call to position fiscal 2026 as a reset year, emphasizing a leaner cost base, stronger balance sheet, and growth in medical cannabis and Europe despite missing consensus estimates for Q4 revenues and EPS. The company highlighte

Tone
Negative 38/100
Event
Earnings
Published
16 Jun 2026 11:39
Source
TradingView
TradingView Direct company coverage

Canopy Growth Q4 Earnings Call Highlights

Canopy Growth (CGC) reported higher fiscal fourth-quarter revenue, emphasizing restructuring efforts and the acquisition of MTL Cannabis have created a stronger balance sheet. The company improved its financial position by CAD 304 million in fiscal 2026, transitioning from net de

Tone
Positive 73/100
Event
Deals and strategy
Published
16 Jun 2026 03:40
Source
TradingView
MJBizDaily Direct company coverage

Canopy Growth reports big jump in medical cannabis revenue

Canopy Growth Corp. saw significant gains in its medical cannabis and international markets in fiscal 2026, with a 27% increase in Canadian medical cannabis revenue and a 69% surge in international revenue. These results reflect the company's restructuring efforts, focus on cost

Tone
Positive 73/100
Event
Earnings
Published
16 Jun 2026 03:10
Source
MJBizDaily